Search
ImmPACT Bio's CEO on bispecifc CAR-T cells for cancer and autoimmune disease
Sumant Ramachandra describes why ImmPACT's programs target more than one antigen and the case for CD19/CD20 in oncology and autoimmune.
Feb 1, 2024
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.
bottom of page